Donkena Krishna Vanaja, Young Charles Y F
Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Adv Prev Med. 2011;2011:281863. doi: 10.4061/2011/281863. Epub 2011 Jun 8.
Prostate cancer is the second common cancer in men worldwide. The prevention of prostate cancer remains a challenge to researchers and clinicians. Here, we review the relationship of vitamin D and sunlight to prostate cancer risk. Ultraviolet radiation of the sunlight is the main stimulator for vitamin D production in humans. Vitamin D's antiprostate cancer activities may be involved in the actions through the pathways mediated by vitamin D metabolites, vitamin D metabolizing enzymes, vitamin D receptor (VDR), and VDR-regulated genes. Although laboratory studies including the use of animal models have shown that vitamin D has antiprostate cancer properties, whether it can effectively prevent the development and/or progression of prostate cancer in humans remains to be inconclusive and an intensively studied subject. This review will provide up-to-date information regarding the recent outcomes of laboratory and epidemiology studies on the effects of vitamin D on prostate cancer prevention.
前列腺癌是全球男性中第二常见的癌症。前列腺癌的预防对研究人员和临床医生来说仍然是一项挑战。在此,我们综述维生素D和阳光与前列腺癌风险的关系。阳光中的紫外线辐射是人体产生维生素D的主要刺激因素。维生素D的抗前列腺癌活性可能通过维生素D代谢产物、维生素D代谢酶、维生素D受体(VDR)和VDR调控基因介导的途径发挥作用。尽管包括使用动物模型在内的实验室研究表明维生素D具有抗前列腺癌特性,但它是否能有效预防人类前列腺癌的发生和/或进展仍尚无定论,是一个深入研究的课题。本综述将提供有关维生素D对前列腺癌预防作用的实验室和流行病学研究最新成果的信息。